AFERIAN PLC

Net Asset Value • Jun 6, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4110Q

Amino Technologies PLC

06 June 2018

6 June 2018

AMINO TECHNOLOGIES PLC

("Amino", the "Company" or the "Group")

Appointment of Joint Broker

Amino Technologies plc (LSE: AMO), the global media and entertainment technology solutions provider, is pleased to announce the appointment of Liberum Capital Limited ("Liberum") as its Joint Broker with immediate effect. Liberum will work alongside finnCap Ltd, the Company's existing Nomad and Joint Broker.

- ENDS -

For further information please contact: 

Amino Technologies PLC	+44 (0)1954 234100
Donald McGarva, Chief Executive Officer
Mark Carlisle, Chief Financial Officer
finnCap Ltd (NOMAD and Joint Broker)	+44 (0)20 7220 0500
Matt Goode / Carl Holmes / Simon Hicks (Corporate Finance)
Simon Johnson / Tim Redfern (Corporate Broking)
Liberum Capital Limited (Joint Broker)	+44 (0)20 3100 2000
Cameron Duncan / Bidhi Bhoma

FTI Consulting LLP (Financial PR)	+44 (0)20 3727 1000
Jamie Ricketts / Alex Le May / Darius Alexander

About Amino Technologies plc

Amino Technologies plc (LSE AIM: AMO) is a global media and entertainment technology solutions provider to major network operators and service providers in over 100 countries. Amino's award-winning solutions enable operators to deliver advanced multiscreen TV experiences to their customers. Since its founding in 1998, the company has sold more than 10 million devices. Amino Technologies plc is headquartered near Cambridge, in the UK, and is listed on the AIM market of the London Stock Exchange. www.aminocom.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

APPQELFBVQFEBBQ